Search results
Results From The WOW.Com Content Network
Grifols. Grifols, S.A. ( Catalan: [ˈɡɾifuls]) is a Spanish multinational pharmaceutical and chemical manufacturer. Principally a producer of blood plasma –based products, a field in which it is the European leader and largest worldwide, [3] [4] the company also supplies devices, instruments, and reagents for clinical testing laboratories .
Grifols said its board held an extraordinary meeting over the weekend to study a preliminary offer presented by Brookfield and the founding family, which has a nearly 30% stake. They asked the ...
This list displays all 8 Spanish companies in the Fortune Global 500, which ranks the world's largest companies by annual revenue. The figures below are given in millions of US dollars and are for the fiscal year 2022. [1] Also listed are the headquarters location, net profit, number of employees worldwide and industry sector of each company.
This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.
This story was initially published on the Benzinga India Portal. The Indian rupee plummeted to a historic low on Thursday, driven by strong dollar demand from local importers and likely capital ...
Grifols has denied the accusations and also filed a lawsuit in the United States against the fund and its founder. Srinivasan will start on Sept. 16, succeeding Alfredo Arroyo, who is retiring ...
Employment website. An employment website is a website that deals specifically with employment or careers. Many employment websites are designed to allow employers to post job requirements for a position to be filled and are commonly known as job boards. Other employment sites offer employer reviews, career and job-search advice, and describe ...
GLP-1 drugs for weight loss grew as a portion of employers' overall medical claims spending to 8.9% in 2024 from 6.9% in 2023, the trade group's survey found. Only about 26% of employers offered ...